[Evaluation of coronary risk and its relationship to health actions in hypertensive patients]

Viviane Rassele Silva1, Maria Del Carmen Bisi Molina2, Nagela Valadão Cade2

  • 1Secretaria Municipal de Saúde, Prefeitura Municipal de Vitória, Vitória, ES, Brasil.

Insights

A study on hypertensive patients found that nearly half had high coronary risk. The number of prescribed medications was the only factor significantly linked to this high risk.

Area of Science:

  • Cardiology
  • Public Health
  • Hypertension Management

Background:

  • Hypertension is a major risk factor for acute coronary events.
  • Effective management of hypertension is crucial for cardiovascular health.
  • Assessing coronary risk in hypertensive patients is vital for preventive strategies.

Purpose of the Study:

  • To evaluate the coronary risk in hypertensive patients using Framingham criteria.
  • To examine the relationship between health actions and coronary risk in this population.
  • To identify factors associated with high coronary risk among hypertensive individuals.

Main Methods:

  • Observational, cross-sectional study involving 330 hypertensive patients.
  • Data collected from medical records, including coronary risk, blood pressure, visits, educational activities, and prescribed drugs.
  • Statistical analysis using ANOVA and paired t-test.

Main Results:

  • 34.8% had low coronary risk, 20.4% had average risk, and 44.8% had high risk.
  • A significant relationship was found between the amount of prescribed medications and high coronary risk.
  • No significant relationship was observed between visits, educational activities, and coronary risk.

Conclusions:

  • A substantial proportion of hypertensive patients in the study population face a high risk of coronary events.
  • Prescribed medication load is a key indicator associated with elevated coronary risk in hypertensive patients.
  • Further research into optimizing medication regimens and adherence is warranted for cardiovascular risk reduction.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
880
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
437
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
642
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
503
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
805